Could a second clot drug boost stroke recovery?
NCT ID NCT07290751
First seen Jan 04, 2026 · Last updated May 14, 2026 · Updated 18 times
Summary
This study tests whether adding a drug called tirofiban after standard clot-busting treatment helps people who had a stroke and aren't improving enough. About 976 adults will receive either tirofiban or a placebo for 24 hours, then standard care. The goal is to see if more people can regain independence at 90 days without increasing bleeding risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Anzhen Hospital,Capital Medical University
RECRUITINGBeijing, Beijing Municipality, 101118, China
Conditions
Explore the condition pages connected to this study.